Revenue: The sum of all revenue fields included for a company's operating activities.
Corcept Therapeutics Incorporated (CORT) had Revenue of $157.21M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$157.21M |
$20.29M |
|
$2.40M |
|
$154.81M |
|
$153.80M |
|
$3.42M |
|
$6.20M |
|
$9.62M |
|
$9.62M |
|
$20.55M |
|
$20.55M |
|
$20.55M |
|
$20.55M |
|
$3.42M |
|
$3.88M |
|
104.11M |
|
119.82M |
|
$0.19 |
|
$0.17 |
|
| Balance Sheet Financials | |
$438.50M |
|
$2.54M |
|
$407.95M |
|
$846.46M |
|
$143.07M |
|
-- |
|
$20.10M |
|
$163.17M |
|
$683.28M |
|
$683.28M |
|
$683.28M |
|
105.98M |
|
| Cash Flow Statement Financials | |
$5.13M |
|
$-3.17M |
|
$-39.80M |
|
$127.67M |
|
$89.82M |
|
$-37.85M |
|
$21.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.47% |
|
2.17% |
|
2.17% |
|
-- |
|
6.12% |
|
12.90% |
|
$5.02M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.17 |
|
2.54 |
|
35.39 |
|
3.01% |
|
3.01% |
|
2.43% |
|
3.01% |
|
$6.45 |
|
$0.04 |
|
$0.04 |
|